Procter Gamble Health Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5261 as of 18 May 15:30 . The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 7 quarters. This represents a CAGR of -100.00% The p/e ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 to 62.6 over 1 quarters. This represents a CAGR of 0.00% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The market cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore to ₹ 11347 crore over 1 quarters. This represents a CAGR of 0.00% The revenue of Procter & Gamble Health Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 378.22 crore. This represent the decline of -100% The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Dec '25 revenue of ₹ 255.6 crore. This represent the decline of -8.14% The ebitda of Procter & Gamble Health Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 114.82 crore. This represent the decline of -100% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Dec '25 ebitda of ₹ 94.4 crore. This represent the decline of 0% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 45 crore to ₹ 67.8 crore over 7 quarters. This represents a CAGR of 26.39% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 7 quarters. This represents a CAGR of -100.00% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 69.89 % over 2 quarters. This represents a CAGR of 13201.02% .

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Procter & Gamble Health Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Procter & Gamble Health Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Procter & Gamble Health Ltd is 8,734 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 11,059 Cr

What are the key factors driving the stock performance of Procter & Gamble Health Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Procter & Gamble Health Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Procter & Gamble Health Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 18, 2026, the Procter & Gamble Health Ltd stock price is INR ₹5261.9. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4802.25.

How do dividend payouts of Procter & Gamble Health Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Procter & Gamble Health Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.